Cresco Lab's Chicago PopUp and New Zealand Accepts Cultivation Apps

RIVERSIDE, Calif. - April 13, 2020 - PRLog -- Cresco Labs announces the opening of a cannabis pop-up retail in Chicago, making it the first exclusively adult-use marijuana retail location downtown. Upon its debut, the shop will be accepting online orders only with staggered pick-up times to abide by COVID19 precautions. Cresco won two licenses through the city's lottery system.

In Colorado, regulators ease cannabis industry hiring restrictions, allowing businesses to employ furloughed casino workers without additional background checks. Because staff members licensed by the state's gaming commission require similar credentials to marijuana company employees, along with mandated casino closures and the designation of cannabis as essential in light of the current pandemic, the move was seen as a logical way to benefit both sectors.

Columbia Care becomes the first dispensary in Delaware to receive approval for medical marijuana delivery services, under an emergency program implemented by regulators in response to the coronavirus outbreak. Columbia Care beat other businesses to the punch with a digital infrastructure already in place to accommodate delivery, however other MMJ dispensaries are expected to follow under the expedited approval process.

Former NFL player Kyle Turley comes under fire from the FDA and FTC for advertising that CBD products can prevent, mitigate, and cure coronavirus, on his CBD company, NeuroXPF's website. In response to the official warning letter, Turley maintains his stance that CBD regulates the immune system thereby helping fight off COVID19 and asks for definitive clarification on marketing guidelines from the federal agencies.

In finance Innovative Industrial Properties enters into a sale-leaseback agreement with Ascend Wellness Holdings, purchasing a Massachusetts cultivation and processing facility for 26.8 million dollars, with an additional 22.2 million reimbursement for tenant improvements. The transaction is the third and largest of its kind between the two companies.

In Canada, online medical cannabis marketplace Cannalogue applies to conduct research into whether the use of marijuana can reduce the severity of COVID19 symptoms. They hope clinical trials will prove that the anti-inflammatory and immunity-boosting properties of cannabinoids can provide some relief to afflicted patients, and are awaiting approval from Health Canada. The company has also introduced a compassionate care program to provide product discounts of up to 50 percent off for those facing financial difficulty due to the pandemic.

New Zealand's Ministry of Health starts accepting applications for medical cannabis cultivation and manufacturing licenses, after finalizing regulations for the country's program in December. The rules will allow doctors to prescribe marijuana without a specialist referral, as well as specify permitted products, such as oils, tablets, and flower for vaping, all of which must be GMP certified.

Written by Jacqui Verdura and Micah Tatum]

https://youtu.be/BRQ2z1WmoDM